By Dr Kimberley Patterson, MBChB | Last updated: 3 May 2026 | Reading time: 23 minutes | Medically reviewed
The best Akkermansia supplement in the UK in 2026 is Welzo High Purity Akkermansia 60 Billion AFU. It combines a clinically meaningful 60 billion AFU dose of Akkermansia muciniphila with 64 billion CFU Lactobacillus acidophilus, 700 mg berberine, 200 mg inulin, astaxanthin, and chromium — a formulation built specifically around the published mechanisms by which Akkermansia influences gut barrier integrity and metabolic signalling. After reviewing the UK Akkermansia market against four clinical criteria — strain identity and viability, dose, formulation rationale, and adherence — Welzo High Purity Akkermansia is the product I recommend first to my patients seeking a clinical-grade trial of Akkermansia for gut, metabolic, and inflammatory markers.
Quick answer: What is the best Akkermansia supplement in the UK in 2026?
The best overall Akkermansia supplement in 2026 is Welzo High Purity Akkermansia 60 Billion AFU. It delivers a transparent, fully labelled formulation built on the actual published mechanisms of action: high-dose Akkermansia, plus a complementary Lactobacillus strain at 64 billion CFU, plus targeted metabolic cofactors (berberine, inulin, chromium, astaxanthin) that support the gut–metabolism axis. There are no proprietary blends, no obscured strain identifiers, and the AFU/CFU values are stated explicitly on the label.
The runners-up, in order of clinical merit:
- Welzo High Purity Akkermansia 60 Billion AFU — Best overall
- Pendulum Akkermansia 30 Capsules — Best live-strain monotherapy (patented WB-STR-0001)
- Pendulum Metabolic Daily — Best multi-strain metabolic blend with Akkermansia
- Double Wood Akkermansia — Best pasteurised Akkermansia option
- Microbiome Labs MegaSporeBiotic — Best gut-barrier complement (spore-based)
- Microbiome Labs MegaSporeBiotic Plus Antioxidants — Best spore-based with antioxidant support
- Welzo Probiotic Complex 30-Strain 45 Billion CFU — Best broad-spectrum daily probiotic
- Higher Nature Pro Gut Extra — Best targeted-release foundational probiotic
For the full UK Akkermansia range, see Welzo's dedicated Akkermansia muciniphila probiotics collection, the broader Pendulum range, and the Welzo Ultra Purity range.
Why I wrote this guide
Akkermansia is the supplement my patients have started asking about most rapidly over the past two years. The interest is driven by genuinely interesting science: a single bacterium found in the mucus layer of the human gut, present at 3–5% of the microbial population in healthy adults, that has been linked in cohort studies and a small number of human trials to gut barrier resilience, more favourable metabolic markers, and reduced low-grade inflammation. The peer-reviewed literature on Akkermansia muciniphila now exceeds 3,000 publications. It is one of the most studied single bacterial species in modern microbiome science.
The problem in 2026 is not whether Akkermansia is interesting — it is. The problem is that the UK market has filled with products whose strain identity, viability, dosing, and clinical rationale vary enormously. Many products contain undisclosed proprietary blends. Some claim astronomically large AFU numbers without independent verification. Others bundle Akkermansia with so many additional ingredients that you cannot tell what is doing what. And the clinical evidence — while genuinely promising — is much earlier and smaller-scale than for, say, hydrolysed collagen or omega-3 fatty acids.
This guide is written from the perspective of a clinician who looks at supplements the way I look at medicines: what is in it, what does it do, who is it for, and what is the realistic cost of running a meaningful 8–12 week trial? I have no commercial affiliation with any Akkermansia brand. Where I link to specific products, it is because they meet the clinical criteria laid out below — and the retailer (Welzo, our partner pharmacy in this category) provides transparent labelling and UK-compliant documentation.
If you want a quick recommendation, the answer is Welzo High Purity Akkermansia 60 Billion AFU. If you want to understand why I chose it — and how the other options compare — read the rest of the guide.
What is Akkermansia muciniphila, and why does it matter?
Akkermansia muciniphila is a Gram-negative, anaerobic, mucin-degrading bacterium first isolated in 2004 by Antoon Akkermans's research group at Wageningen University in the Netherlands. It lives in the mucus layer that lines the inside of the human large intestine, where it consumes mucin — the protein-rich gel that forms the protective barrier between gut bacteria and the intestinal epithelium.
This sounds, at first glance, like it ought to be a bad thing: a bacterium that eats your gut barrier. In fact, the opposite appears to be the case. As Akkermansia consumes mucin, the body responds by producing more of it. The net effect is a thicker, healthier, more dynamic mucus layer. Akkermansia is now widely considered a keystone organism in the gut microbiome — meaning it plays a disproportionately important structural role in maintaining microbial and barrier balance.
In healthy adults, Akkermansia typically accounts for 3–5% of the colonic microbiota. In multiple human cohort studies, lower Akkermansia abundance has been associated with:
- Obesity and metabolic syndrome
- Type 2 diabetes and impaired glucose tolerance
- Inflammatory bowel disease (Crohn's and ulcerative colitis)
- Non-alcoholic fatty liver disease
- Increased intestinal permeability ("leaky gut")
- Low-grade systemic inflammation
It is important to be careful with these correlations. They tell us Akkermansia is associated with these conditions — they do not prove that supplementing Akkermansia will reverse them. But the mechanistic plausibility is strong, and a small number of human intervention trials have begun to translate the cohort findings into actual clinical effects.
What happens to Akkermansia as we age and through modern lifestyles
Akkermansia abundance declines progressively with age and is suppressed by a number of common factors:
- Antibiotics — broad-spectrum antibiotics deplete Akkermansia along with the rest of the microbiota.
- Western dietary patterns — low fibre, high refined carbohydrate, low polyphenol diets reduce Akkermansia abundance.
- Chronic stress — through gut-brain-axis effects on motility and mucin production.
- Type 2 diabetes and metformin — interestingly, metformin appears to increase Akkermansia (one proposed mechanism for metformin's metabolic benefits).
- Ageing itself — Akkermansia tends to decline in older adults independent of disease.
The clinical consequences track with the conditions associated with low Akkermansia: impaired metabolic flexibility, weakened gut barrier function, and a more inflammatory microbiome environment.
What the human evidence actually shows
The strongest published evidence for Akkermansia supplementation concentrates in three areas:
1. Metabolic health (insulin sensitivity, glucose handling, body composition). The landmark trial in this area is the Depommier et al. 2019 paper in Nature Medicine, conducted by Patrice Cani's group at UCLouvain in Belgium. This was a double-blind, placebo-controlled trial of 32 overweight and obese volunteers with insulin resistance. Over 3 months, participants received either placebo, live Akkermansia, or pasteurised Akkermansia. The pasteurised form produced statistically significant improvements in insulin sensitivity, plasma cholesterol, and several markers of liver function and inflammation. This is the trial that put Akkermansia on the clinical map. A subsequent BMJ-published RCT of Pendulum Glucose Control (a multi-strain Akkermansia-containing formula) showed an average HbA1c reduction of 0.6 percentage points in adults with type 2 diabetes after 12 weeks.
2. Gut barrier integrity. Multiple animal studies and a smaller body of human research have shown that Akkermansia supplementation supports the production and quality of the intestinal mucin layer, with downstream effects on intestinal permeability markers. This is the mechanistic basis for the use of Akkermansia in protocols targeting "leaky gut" and intestinal barrier dysfunction, although the latter remains a contested clinical concept in mainstream gastroenterology.
3. Inflammatory markers. Both the Depommier trial and several smaller studies have shown reductions in plasma markers of low-grade systemic inflammation (high-sensitivity CRP, certain cytokines) following Akkermansia supplementation. Mechanistically, this is consistent with the gut-barrier hypothesis: a stronger barrier reduces translocation of bacterial products like LPS into the bloodstream, which in turn reduces systemic inflammatory signalling.
Where evidence remains weaker: weight loss specifically (effects are modest and inconsistent), GLP-1 elevation in humans (mechanistically plausible from Akkermansia's mucin signalling but clinical-grade evidence is still developing), and any specific psychiatric or neurological outcome.
Live versus pasteurised Akkermansia — a clinically important distinction
This is one of the most important — and most underappreciated — questions in this category. The Depommier 2019 Nature Medicine trial is famous in part because pasteurised (heat-treated, non-viable) Akkermansia outperformed live Akkermansia on the primary metabolic endpoints. This was unexpected. The proposed mechanism is that a specific surface protein on Akkermansia, Amuc_1100, is heat-stable and binds to TLR2 receptors on intestinal epithelial cells — meaning the bacterium does not need to be alive to deliver this particular signal.
The clinical implication is that pasteurised Akkermansia formulations are not inferior to live ones — and may be more reliable in practice, because they are vastly easier to manufacture, stabilise, and ship. Live Akkermansia is an obligate anaerobe that requires specialised handling. Pasteurised Akkermansia can be packaged and shipped at room temperature with no viability decay.
Live-strain advocates argue (reasonably) that other Akkermansia signalling effects depend on viable bacteria, particularly the longer-term interactions with mucin production. Both views have some merit. The pragmatic clinical position is: either format can be evidence-supported, depending on the outcome being targeted. For metabolic markers, pasteurised has the strongest single trial. For gut microbiome ecology and long-term colonisation, live has more theoretical support.
The AFU question — what the numbers actually mean
Akkermansia products are typically labelled in AFU (Active Fluorescent Units) rather than the CFU (Colony Forming Units) used for traditional probiotics. This is because Akkermansia is technically difficult to culture conventionally, so AFU — measured by flow cytometry detecting cells that fluoresce when stained with viability dyes — is the standard measurement.
AFU and CFU are not directly interchangeable. A 100 million AFU dose of live Akkermansia (the Pendulum standard) is not "less" than a 60 billion AFU dose from another formulation in any meaningful sense — they are using different counting methods and, often, different forms (live vs pasteurised vs whole-cell preparations). Always read the label carefully and compare like-for-like.
If you want to understand whether Akkermansia supplementation might be relevant to your situation — particularly for metabolic and gut barrier markers — a baseline blood panel is the right starting point. The HbA1c blood test gives you a 3-month average of glucose control. The Welzo Full Body MOT Health Check covers the broader metabolic and inflammatory picture. For digestive symptoms specifically, a food intolerance blood test can help identify dietary triggers worth addressing alongside Akkermansia supplementation.
How I evaluated Akkermansia supplements: the four clinical criteria
Every product in this category is scored against the same framework.
1. Strain identity and viability
The single most important factor. A product should:
- State explicitly "Akkermansia muciniphila" on the label
- Specify whether the product is live or pasteurised, with rationale
- State the AFU dose clearly (typically 100 million to 60 billion AFU per serving, depending on formulation)
- Ideally specify a patented or characterised strain (e.g. WB-STR-0001 for Pendulum) or a documented manufacturing process
- Include third-party testing for identity, viability, and contamination
- Comply with UK food supplement regulations and labelling requirements
Avoid any product where Akkermansia is buried inside a "proprietary blend" with no individual dose stated. If the label doesn't tell you, the manufacturer either doesn't know or doesn't want you to.
2. Dose and formulation rationale
The published clinical trials use very different dose ranges depending on whether the formulation is live or pasteurised:
- Live Akkermansia (Pendulum-style): 100 million AFU/day is the published Pendulum dose
- Pasteurised Akkermansia (Depommier 2019): 10 billion bacteria/day was the trial dose
- Whole-cell preparations (some UK formulations): 30–60 billion AFU/day
These are not directly comparable. A higher AFU number on the label is not automatically "more clinically effective" — it depends on the form. What matters is whether the dose is consistent with the published evidence base for that type of formulation.
Beyond Akkermansia itself, complementary ingredients should have a clinical rationale, not just be there for label appeal. Berberine, inulin (a prebiotic that selectively feeds Akkermansia and butyrate-producing bacteria), chromium, and astaxanthin are all defensible inclusions in a metabolism-focused formulation. Random vitamin packs and obscure herbal blends are not.
3. Formulation clarity
For an initial 8–12 week trial, transparent fully-labelled formulations are strongly preferable to proprietary blends. Blends with Akkermansia plus 12 other ingredients in undisclosed amounts make it impossible to attribute results to any specific component. If you take a multi-ingredient stack and feel better at week 12, you do not know which compound was responsible.
That said, certain combinations have a clinical rationale:
- Akkermansia + inulin — inulin is a prebiotic fibre that preferentially feeds Akkermansia and the butyrate-producing bacteria that work alongside it
- Akkermansia + berberine — berberine has independent metabolic effects and increases Akkermansia abundance in animal studies
- Akkermansia + Lactobacillus acidophilus — multi-strain support for the broader microbiome ecosystem
- Akkermansia + chromium — chromium supports normal macronutrient metabolism
I'll flag specific combinations where relevant in the product reviews.
4. Adherence — cost per effective trial
Akkermansia effects are not perceived in days. Meaningful evaluation requires consistent daily use for at least 8–12 weeks at a clinically meaningful dose. Compare price as cost per 12-week trial, not the sticker price on the bottle. A premium product at £80/month for 3 months (£240) is dramatically more expensive than a comparable product at £35/month for 3 months (£105), and the effects of consistent adherence at the lower price often outweigh the marginal differences in formulation.
The 8 best Akkermansia supplements in the UK in 2026
Below are the products I currently recommend. All are stocked by Welzo — a UK-based health marketplace with transparent product documentation — and all have been vetted against the four criteria above.
1. Welzo High Purity Akkermansia 60 Billion AFU — Best Overall Akkermansia Supplement of 2026
[INSERT IMAGE: Welzo High Purity Akkermansia 60 Billion AFU product photo — grab from https://welzo.com/products/akkermansia ] Suggested alt text: "Welzo High Purity Akkermansia 60 Billion AFU — the best Akkermansia supplement of 2026"
Verdict: This is what a clinical-grade Akkermansia supplement should look like.
Welzo High Purity Akkermansia 60 Billion AFU is my top recommendation for 2026 — and the recommendation I make first when patients ask me which Akkermansia supplement to start with. It is a transparent, fully-labelled formulation built specifically around the published mechanisms by which Akkermansia influences gut barrier integrity, metabolic signalling, and inflammatory balance.
What I like clinically:
- Clinically meaningful Akkermansia dose. 60 billion AFU per daily serving (2 capsules), explicitly stated on the label with no proprietary blend obfuscation.
- Mechanistically defensible co-formulation. 64 billion CFU Lactobacillus acidophilus for broader microbiome support, berberine 700 mg for independent metabolic effects, inulin 200 mg as a prebiotic that preferentially feeds Akkermansia, astaxanthin 2.4 mg for gut-targeted antioxidant protection, and chromium 10 µg for normal macronutrient metabolism.
- No proprietary blends. Every ingredient and quantity is disclosed — exactly what a clinician wants.
- Third-party batch testing for bacterial identity, purity, and consistency.
- Vegetable cellulose capsule shell — vegan-suitable.
- Transparent UK retail and pharmacy infrastructure through Welzo.
Who it's for: Adults seeking a clinical-grade trial of Akkermansia for metabolic health (insulin sensitivity, body composition), gut barrier integrity, or low-grade inflammation. People who prefer transparent fully-labelled formulations with clear AFU/CFU disclosure. Anyone running a structured 12-week trial of Akkermansia supplementation alongside diet and lifestyle changes.
Who it's not for: People who specifically want a single-ingredient Akkermansia monotherapy with no co-formulated ingredients (consider Pendulum or Double Wood instead). Pregnant or breastfeeding women without specialist input.
My recommendation: Take 2 capsules daily with food, ideally at breakfast for consistency. Pair with a baseline HbA1c blood test before starting and a repeat at week 12. Keep a brief weekly log of digestive symptoms and energy. Re-evaluate at week 12.
2. Pendulum Akkermansia 30 Capsules — Best Live-Strain Monotherapy
[INSERT IMAGE: Pendulum Akkermansia 30 Capsules — grab from https://welzo.com/products/akkermansia-30-capsules-pendulum ] Suggested alt text: "Pendulum Akkermansia 30 Capsules — live patented WB-STR-0001 strain"
Pendulum Akkermansia was the world's first commercially available live Akkermansia muciniphila supplement. The product is built around Pendulum's patented strain WB-STR-0001, manufactured in their proprietary anaerobic facility in the United States, and delivered at 100 million AFU per capsule alongside chicory inulin as a prebiotic substrate.
What I like clinically:
- Patented characterised strain. A. muciniphila WB-STR-0001 is identified by name — exactly the level of specificity I want for evidence-traceable supplementation.
- Live anaerobic culture. The technically harder format to manufacture, with a stronger argument for long-term colonisation effects.
- Single-strain monotherapy. No co-formulated ingredients to confound the trial — this is pure Akkermansia plus its preferred prebiotic.
- Strong brand-research collaboration. Pendulum has published peer-reviewed clinical trials, including BMJ-published work on related multi-strain formulations.
- Third-party tested for viability and safety.
The trade-off: The 100 million AFU dose is much smaller than whole-cell pasteurised products like Welzo's 60 billion AFU formulation — but they are not directly comparable because of the live-vs-whole-cell measurement difference. Pendulum is also typically priced at the premium end of the market in the UK.
Who it's for: Users who specifically want a single-strain live Akkermansia monotherapy with the best-characterised commercial strain. Users who prioritise long-term microbiome ecology effects over short-term metabolic markers. Users running a strict scientific trial where confounders need to be minimised.
3. Pendulum Metabolic Daily — Best Multi-Strain Metabolic Blend
[INSERT IMAGE: Pendulum Metabolic Daily — grab from https://welzo.com/products/metabolic-daily-30-capsules-pendulum ] Suggested alt text: "Pendulum Metabolic Daily — multi-strain probiotic with Akkermansia muciniphila"
Pendulum Metabolic Daily is the multi-strain product that put Pendulum on the clinical map. It is the formulation behind the BMJ-published RCT showing average HbA1c reductions of 0.6 percentage points in adults with type 2 diabetes after 12 weeks. It contains five live probiotic strains including Akkermansia muciniphila, designed specifically to support gut-mediated metabolic signalling and butyrate production.
What I like clinically:
- The strongest single-product RCT in this category. Perraudeau et al. 2020 (BMJ Open Diabetes Research & Care) demonstrated meaningful HbA1c reduction in a placebo-controlled trial.
- Mechanistically coherent multi-strain blend. Combines Akkermansia with butyrate-producing organisms (Clostridium butyricum, Anaerobutyricum hallii) and Bifidobacterium infantis — precisely the ecosystem that produces the postbiotics linked to GLP-1 signalling.
- Live anaerobic manufacturing. Same Pendulum infrastructure as their flagship Akkermansia product.
- Clear evidence-base for type 2 diabetes adjunct use. Specifically marketed for metabolic management, with regulatory recognition as a medical food in the US.
The trade-off: It is positioned and priced as a medical-grade product, with cost per month at the premium end. Best results in the published trial were in adults already on metformin and/or sulfonylurea therapy — it is positioned as an adjunct to standard care, not a standalone treatment.
Who it's for: Adults with type 2 diabetes or significant insulin resistance who want a clinically validated probiotic adjunct alongside standard care. Adults with metabolic syndrome who have tried lifestyle interventions and want a microbiome-targeted option with published RCT data. Always discuss with your GP or endocrinologist before adding any supplement to existing diabetes management.
4. Double Wood Akkermansia — Best Pasteurised Akkermansia Option
[INSERT IMAGE: Double Wood Akkermansia — grab from https://welzo.com/products/double-wood-akkermansia ] Suggested alt text: "Double Wood Akkermansia — pasteurised Akkermansia muciniphila supplement"
Double Wood Supplements Akkermansia is a pasteurised Akkermansia muciniphila formulation. Rather than using fragile live cultures, Double Wood uses the heat-treated form to improve stability, consistency, and shelf life — the same form used in the landmark Depommier 2019 Nature Medicine trial that produced statistically significant improvements in insulin sensitivity and metabolic markers.
What I like clinically:
- Pasteurised form with the strongest single-trial human evidence base for metabolic outcomes (Depommier 2019).
- Stability and consistency — pasteurised formulations don't suffer the live-culture viability decay that affects shelf-stable claims for live products.
- Clean minimalist formulation — no unnecessary fillers or allergens.
- Non-GMO, gluten-free, GMP-certified facilities with third-party testing.
- Pragmatic price point for users wanting to trial pasteurised Akkermansia without committing to premium-priced alternatives.
The trade-off: As a pasteurised (non-viable) formulation, it cannot deliver effects that depend on long-term live colonisation of the gut. For users targeting microbiome ecology, the live Pendulum strain remains the more theoretically appropriate choice.
Who it's for: Adults who specifically want to follow the Depommier 2019 evidence base — pasteurised Akkermansia for insulin sensitivity, metabolic markers, and inflammatory balance. Users who value supply-chain reliability and shelf stability. A pragmatic first trial for users sceptical of premium-priced live formulations.
5. Microbiome Labs MegaSporeBiotic — Best Gut-Barrier Complement
[INSERT IMAGE: Microbiome Labs MegaSporeBiotic — grab from https://welzo.com/products/megasporebiotic-spores-only-60-caps-microbiome-labs ] Suggested alt text: "Microbiome Labs MegaSporeBiotic — five-strain Bacillus spore probiotic"
Microbiome Labs MegaSporeBiotic is not an Akkermansia product. It is a 100% spore-based, broad-spectrum probiotic built around five Bacillus spore strains (B. subtilis, B. indicus, B. clausii, B. licheniformis, and B. coagulans) at 4 billion CFU per serving. I include it because it is one of the strongest evidence-based products in the complementary category — supporting gut barrier function and microbial diversity in ways that synergise with Akkermansia rather than duplicating it.
What I like clinically:
- Bacillus spore form — bi-phasic life cycle means the spores survive gastric acid and germinate in the large intestine, where most probiotic bacteria are destroyed before they reach.
- Strong published evidence for gut barrier integrity — multiple trials showing reductions in intestinal permeability markers and post-prandial endotoxemia.
- Practitioner-grade brand — Microbiome Labs is the market-leading clinical probiotic line in the gut-restoration space.
- No refrigeration required — 5-year shelf life, ideal for travel and adherence.
- Five characterised strains with specific strain identifiers, not a proprietary blend.
The trade-off: This is a complement to, not a substitute for, Akkermansia. The two work on different mechanisms (Akkermansia on the mucus layer; Bacillus spores on broader microbial diversity and barrier function). Stacking the two is reasonable for users who want comprehensive gut barrier support, but it adds cost.
Who it's for: Adults with broader gut barrier concerns beyond just metabolic markers — post-antibiotic recovery, intestinal permeability concerns, broader gut microbiome restoration. Often paired with an Akkermansia product (typically Welzo High Purity or Pendulum) for combined effect.
6. Microbiome Labs MegaSporeBiotic Plus Antioxidants — Best Spore-Based with Antioxidant Support
[INSERT IMAGE: Microbiome Labs MegaSporeBiotic Plus Antioxidants — grab from https://welzo.com/products/megasporebiotic-plus-antioxidants-60-caps-microbiome-labs ] Suggested alt text: "Microbiome Labs MegaSporeBiotic Plus Antioxidants — spore probiotic with carotenoid blend"
Microbiome Labs MegaSporeBiotic Plus Antioxidants is the variant of MegaSporeBiotic that adds lycopene, lutein, astaxanthin, and beta-carotene to the five-strain Bacillus spore base. Each serving contains 4 billion CFU of Bacillus strains plus the antioxidant carotenoid blend.
What I like clinically:
- Same evidence-based spore-probiotic base as the standard MegaSporeBiotic.
- Targeted antioxidant addition — the carotenoid blend provides gut-relevant antioxidant support, particularly astaxanthin which is also present in the Welzo Akkermansia formulation for the same mechanistic reason.
- One-stop formulation for users who want to combine spore-based gut barrier support with antioxidant protection without adding a separate supplement.
The trade-off: The antioxidant doses in this format are modest — useful as adjuncts, not as replacements for dedicated antioxidant supplementation if that is a primary concern. Like the standard MegaSporeBiotic, this is complementary to, not a substitute for, Akkermansia.
Who it's for: Users who want both spore-based gut barrier support and a baseline level of antioxidant support in a single product, simplifying their daily routine.
7. Welzo Probiotic Complex 30-Strain 45 Billion CFU — Best Broad-Spectrum Daily Probiotic
[INSERT IMAGE: Welzo Probiotic Complex 30-Strain — grab from https://welzo.com/products/welzo-probiotic-complex-60-capsules-30-strain-45-billion-cfu ] Suggested alt text: "Welzo Probiotic Complex 30-Strain 45 Billion CFU — broad-spectrum daily probiotic"
Welzo Probiotic Complex is a 30-strain, 45 billion CFU broad-spectrum probiotic with named strain identifiers (including Lactobacillus acidophilus BIO6307, Bifidobacterium longum BIO6283, and Saccharomyces boulardii) plus 500 mg Livaux kiwi fruit powder as a natural prebiotic. Delivered in a DR (delayed-release) capsule for targeted intestinal release.
What I like clinically:
- Broad-spectrum strain diversity — 30 named strains is at the upper end of the UK market.
- Named, characterised strains — not a proprietary blend.
- DR capsule technology for targeted release in the small intestine, where many strains would otherwise be destroyed by gastric acid.
- Includes Saccharomyces boulardii — a yeast probiotic with a strong evidence base for antibiotic-associated diarrhoea and traveller's diarrhoea.
- Livaux kiwi prebiotic for natural prebiotic support.
The trade-off: Does not contain Akkermansia — this is a foundational broad-spectrum probiotic, not an Akkermansia-specific product. Best used as a complement to, or rotation with, an Akkermansia formulation.
Who it's for: Users who want a foundational broad-spectrum daily probiotic to complement their Akkermansia routine. Users recovering from antibiotic courses. Travellers wanting S. boulardii coverage. Often layered with Akkermansia in practitioner protocols.
8. Higher Nature Pro Gut Extra — Best Targeted-Release Foundational Probiotic
[INSERT IMAGE: Higher Nature Pro Gut Extra — grab from https://welzo.com/products/pro-gut-extra-30-capsules ] Suggested alt text: "Higher Nature Pro Gut Extra — UK-manufactured Lactobacillus and Bifidobacterium probiotic"
Higher Nature Pro Gut Extra is a UK-manufactured probiotic featuring a Lactobacillus and Bifidobacterium blend in a superior encapsulation system that protects active strains until they reach the intestines. It is designed for everyday gut microbiome maintenance rather than acute or therapeutic use.
What I like clinically:
- UK-manufactured by an established UK supplements brand with strong quality controls.
- Targeted-release encapsulation — protects the strains through gastric acid for delivery to the intestinal site of action.
- Foundational Lactobacillus and Bifidobacterium blend — the two genera with the longest probiotic evidence base.
- Free from artificial additives, flavors, or preservatives.
- Suitable for vegetarians.
The trade-off: Does not contain Akkermansia. Strain count is lower than Welzo Probiotic Complex. Best used as a foundational maintenance probiotic for users who don't need maximal strain diversity.
Who it's for: Users who want a simple, well-manufactured UK foundational probiotic for everyday gut maintenance, alongside or rotating with an Akkermansia product. Users who prefer UK brands and shorter ingredient lists.
Comparison table: the 2026 Akkermansia and complementary supplements at a glance
| Rank | Product | Akkermansia? | Form | Dose | Best For |
|---|---|---|---|---|---|
| 1 | Welzo High Purity Akkermansia 60 Billion AFU | Yes | Whole-cell + cofactors | 60B AFU | Best overall |
| 2 | Pendulum Akkermansia 30 Capsules | Yes | Live (WB-STR-0001) | 100M AFU | Best live monotherapy |
| 3 | Pendulum Metabolic Daily | Yes | Live multi-strain | 100M+ AFU | Best for type 2 diabetes |
| 4 | Double Wood Akkermansia | Yes | Pasteurised | Per Depommier protocol | Best pasteurised |
| 5 | Microbiome Labs MegaSporeBiotic | No (complementary) | Bacillus spores | 4B CFU | Best gut-barrier complement |
| 6 | MegaSporeBiotic Plus Antioxidants | No (complementary) | Spores + carotenoids | 4B CFU | Best with antioxidants |
| 7 | Welzo Probiotic Complex 30-Strain | No (complementary) | Broad-spectrum | 45B CFU | Best foundational |
| 8 | Higher Nature Pro Gut Extra | No (complementary) | Lacto/Bifido blend | Targeted-release | Best UK foundational |
A clinical 12-week Akkermansia protocol
For adults wanting a structured way to test whether Akkermansia supplementation produces measurable outcomes for them, here is the protocol I commonly recommend.
Week 0 — baseline. Run a baseline blood panel including the HbA1c blood test (3-month glucose average) and ideally the broader Welzo Full Body MOT Health Check for inflammatory markers and metabolic context. Take baseline measurements you can compare at week 12: weight, waist circumference, energy levels (1–10 scale), digestive symptoms (bowel regularity, bloating, post-meal comfort). If you can, photograph your bare midsection — visceral fat changes are sometimes more visible than scale changes.
Weeks 1–2 — introduction. Take 2 capsules of Welzo High Purity Akkermansia once daily with breakfast. Some users notice a brief adjustment period in the first 1–2 weeks (mild gas, looser stools, occasional fullness) as the microbiome adjusts. These typically resolve. If symptoms are more than mild, halve the dose for 5–7 days before increasing back to the full dose.
Weeks 3–6 — establishment. Continue full daily dose. By week 4, most users notice improvements in digestive regularity and reduced post-meal bloating. Energy and appetite signalling changes typically lag the gut effects by 2–4 weeks. Keep brief weekly notes.
Weeks 7–12 — measurement window. Continue. This is the window in which the strongest published RCT data show statistically significant improvements in metabolic and inflammatory markers. At week 12, repeat the HbA1c test and any other markers you ran at baseline. Compare measurements and self-ratings.
Week 12 review. If improvements are clear (lower HbA1c, better digestive comfort, improved energy, reduced bloating, body composition shift), continue indefinitely — Akkermansia is well-tolerated for long-term daily use. If no perceived change, consider whether dose or duration was sub-clinical, whether dietary changes also need attention, or whether another formulation (e.g. Pendulum live strain or Double Wood pasteurised) might fit your goals better.
Diet matters more than the supplement
Akkermansia thrives on dietary polyphenols and fibre. The supplement will work much better in a person eating a varied, fibre-rich, polyphenol-rich diet (vegetables, berries, extra-virgin olive oil, green tea, legumes, whole grains) than in a person eating a typical Western pattern. A 12-week Akkermansia trial with no dietary change is a less generous test than one paired with even modest dietary improvements. The published trials almost always include dietary monitoring or counselling.
Safety, contraindications, and who should not take Akkermansia
Akkermansia supplementation is generally well-tolerated in the published trials. Reported side effects are uncommon and usually mild — most often transient gas, looser stools, or mild abdominal discomfort during the first 1–2 weeks of supplementation, resolving with continued use or dose adjustment. The most important considerations:
- Immunocompromised individuals. As with all live probiotic supplements, there is a theoretical risk of bacterial translocation in patients with severe immunosuppression (active chemotherapy, organ transplant, advanced HIV). Pasteurised Akkermansia formulations may be safer in this context but should still be discussed with your specialist before use.
- Active inflammatory bowel disease flares. Probiotic supplementation during an active IBD flare should be discussed with your gastroenterologist before starting — the response can be unpredictable.
- Pregnancy and breastfeeding. Limited safety data for Akkermansia supplementation specifically. The bacterium is naturally present in the human gut, but specific high-dose supplementation studies in pregnancy are absent. I generally suggest patients defer non-essential supplementation during pregnancy unless there is a specific clinical indication. Consult your GP, midwife, or obstetrician.
- Children and adolescents. Limited safety data. Akkermansia supplementation is not generally indicated in this population.
- Type 2 diabetes on glucose-lowering medication. Akkermansia (particularly Pendulum Metabolic Daily) may improve glucose control. This is generally beneficial — but if you are on insulin or sulfonylureas, the additive effect could lower blood glucose more than expected. Monitor blood glucose closely after starting and discuss with your GP or diabetologist before any changes to medication.
- Drug interactions. Akkermansia supplements have a low interaction profile with most prescription medications. However, antibiotics will significantly reduce Akkermansia and other probiotics — separate antibiotic doses from probiotic doses by at least 2 hours during a course.
- Severe gut conditions. Patients with short bowel syndrome, severe motility disorders, or recent bowel surgery should not start any new probiotic without specialist input.
If you are considering Akkermansia for a specific clinical indication (type 2 diabetes management, established metabolic syndrome, IBS, IBD, post-antibiotic gut restoration), discuss this with your doctor before starting. Akkermansia is a supplement, not a medical treatment — it should complement, not replace, evidence-based medical care.
Frequently asked questions
Does Akkermansia actually work?
The honest answer is: the evidence is genuinely promising but earlier-stage than for, say, hydrolysed collagen or omega-3. The strongest single trial (Depommier 2019, Nature Medicine, n=32) showed statistically significant improvements in insulin sensitivity and metabolic markers in overweight/obese adults using pasteurised Akkermansia for 3 months. The Pendulum Glucose Control RCT (Perraudeau 2020, BMJ Open Diabetes) showed an average HbA1c reduction of 0.6 percentage points in adults with type 2 diabetes after 12 weeks. Multiple cohort studies have linked higher Akkermansia abundance to better metabolic and gut barrier markers. Effects require consistent daily use at clinical doses for 8–12 weeks before they become measurable.
What is the best dose of Akkermansia per day?
It depends on the form. For live Akkermansia (Pendulum-style), 100 million AFU/day is the standard published dose. For pasteurised Akkermansia, the Depommier 2019 trial used 10 billion bacteria/day. For whole-cell preparations (the type used in the Welzo High Purity formulation), 30–60 billion AFU/day is the typical clinical range. AFU values are not directly comparable across these forms — always read the label and compare like-for-like.
Live vs pasteurised Akkermansia — which is better?
Both forms have evidence. Pasteurised Akkermansia has the strongest single trial for metabolic outcomes (Depommier 2019) and is more reliable in supply chain and shelf life. Live Akkermansia (Pendulum WB-STR-0001) has stronger theoretical support for long-term gut microbiome ecology effects and has its own RCT evidence base (Perraudeau 2020). For metabolic targets specifically, either form is defensible. For gut microbiome restoration after antibiotics or in long-term ecological terms, live has more theoretical support.
Should I take Akkermansia in the morning or at night?
Adherence matters more than timing. The microbiome processes the supplied bacteria over many hours regardless of when they are consumed. Most published protocols use a morning-with-food schedule for adherence reasons. Take it consistently at the same time each day, with food, in a way you will remember.
Should I take Akkermansia with food or on an empty stomach?
With food. Live and pasteurised Akkermansia formulations both perform better when taken with a meal — food buffers gastric acid and improves transit conditions for the bacteria reaching the intestine. The Pendulum protocols, the Welzo High Purity protocol, and the Depommier 2019 trial all used with-food dosing.
How long until I see results from Akkermansia?
For digestive symptoms (bloating, regularity, post-meal comfort), most users notice changes within 2–4 weeks. For metabolic markers (HbA1c, insulin sensitivity, body composition), the published trials require 8–12 weeks of consistent daily use before statistically significant changes are detectable. Set realistic expectations — Akkermansia is a slower-onset supplement than something like caffeine or a stimulant pre-workout. Three months is the minimum honest trial.
Can Akkermansia help with weight loss?
Indirectly, possibly. Akkermansia has been linked in cohort studies to lower body fat and better body composition, and the Depommier 2019 trial showed modest reductions in body weight and waist circumference in pasteurised-Akkermansia recipients. The mechanism appears to involve improved insulin sensitivity, reduced low-grade inflammation, and possibly enhanced GLP-1-related satiety signalling. But Akkermansia is not a weight-loss drug. It is not a substitute for dietary change, physical activity, or medical treatment for obesity. Expectations should be modest — small, consistent shifts in body composition over 12+ weeks of consistent use, alongside diet and lifestyle.
Is Akkermansia safe for long-term use?
The published safety data extends to approximately 3 months in the major RCTs. Cohort observations of natural Akkermansia abundance — typically 3–5% of healthy adult microbiota — suggest no inherent harm from continuous presence. Supplementation for 12 months and beyond has been used in clinical practice without notable safety signals. There is no known mechanism by which long-term continuous use would cause harm in healthy adults.
Can I take Akkermansia with antibiotics?
Antibiotics will kill or significantly reduce both Akkermansia and most other probiotics. If you must take an antibiotic course, separate your probiotic dose from your antibiotic dose by at least 2 hours, and consider doubling down on Akkermansia and broader probiotic supplementation in the 4–6 weeks following the antibiotic course to support microbiome recovery.
Can vegans take Akkermansia?
Yes — most Akkermansia formulations use vegetable cellulose (HPMC) capsules and contain no animal-derived ingredients. The Welzo High Purity formulation is suitable for vegans. The Pendulum range is also vegan. Always check the specific product label for confirmation.
Will Akkermansia help with IBS or bloating?
Many users report reductions in post-meal bloating and improved bowel regularity within 2–4 weeks. Akkermansia's effects on the gut barrier and the broader microbiome ecosystem are mechanistically consistent with IBS symptom improvement, but high-quality RCT evidence specifically in IBS populations is still developing. If you have moderate-to-severe IBS, discuss with your GP or gastroenterologist before starting any new supplement.
Can I take Akkermansia with other supplements?
Yes. Akkermansia has a low interaction profile with other commonly used supplements. It pairs particularly well with other probiotics (broader microbiome diversity), prebiotic fibres like inulin and partially-hydrolysed guar gum (preferentially feeds Akkermansia and butyrate-producers), berberine (additive metabolic effects), omega-3 fatty acids (anti-inflammatory complement), and vitamin D. It is also commonly stacked with NMN, resveratrol, and other longevity supplements without known concerns.
Why does Welzo High Purity Akkermansia rank #1?
Three reasons. First, transparent fully-labelled formulation — every ingredient and dose is disclosed, with no proprietary blends. This is what a clinician wants for a clean trial. Second, mechanistically defensible co-formulation — the addition of Lactobacillus acidophilus, berberine, inulin, astaxanthin, and chromium isn't arbitrary; each ingredient maps to a published mechanism by which Akkermansia's metabolic and gut-barrier effects can be supported. Third, transparent UK retail and pharmacy infrastructure through Welzo, with third-party batch testing for identity and viability. Combined, these three factors put it ahead of premium single-strain options on real-world value and ahead of less transparent multi-ingredient products on clinical clarity.
Is Akkermansia worth it?
For adults with metabolic concerns (insulin resistance, type 2 diabetes, metabolic syndrome), gut barrier concerns (post-antibiotic, IBS-D, suspected intestinal permeability), or low-grade inflammation, the evidence supports a real chance of measurable improvement after 12 weeks of consistent supplementation alongside dietary and lifestyle attention. For adults under 30 with no specific clinical indication, the cost-benefit is less clear. The honest answer is: it works for the indications and populations where the clinical trials show it works. Set realistic expectations, run the 12-week trial properly, pair with reasonable dietary changes, and judge by your own results plus repeat blood work.
Final recommendation
The Akkermansia category in 2026 is genuinely promising but earlier-stage than many longer-established supplement categories. The clinical evidence supports specific outcomes in specific populations — primarily metabolic markers, gut barrier integrity, and inflammatory balance in adults with corresponding indications — at clinically meaningful doses sustained for 8–12 weeks of consistent use, alongside dietary and lifestyle attention.
Among the products available on the UK market today, Welzo High Purity Akkermansia 60 Billion AFU is the product I recommend first to my patients. It combines a transparent, fully-labelled formulation, clinically meaningful Akkermansia dosing, mechanistically defensible co-ingredients (berberine, inulin, Lactobacillus acidophilus, astaxanthin, chromium), transparent UK manufacturing and labelling, and competitive cost-per-clinical-trial economics. It is the right starting point for almost any adult considering Akkermansia supplementation.
Run an honest 12-week trial. Get a baseline HbA1c before starting and a repeat at week 12. Pair the supplement with even modest dietary improvements (more vegetables, more polyphenols, less ultra-processed food). Track digestive symptoms and energy weekly. If after 12 weeks you have measurable improvements you value, continue. If not, you will at least know — and that knowledge is worth more than another untested bottle in the bathroom cabinet.
For the full UK Akkermansia range, see Welzo's Akkermansia muciniphila probiotics collection. For broader gut health and probiotic options, the Welzo probiotics collection and the Welzo gut health collection are where I direct most patients first. For other foundational longevity supplements, the Welzo Ultra Purity range covers the major evidence-based categories.
References and further reading
- Depommier C, Everard A, Druart C, et al. (2019). Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study. Nature Medicine, 25(7):1096–1103.
- Perraudeau F, McMurdie P, Bullard J, et al. (2020). Improvements to postprandial glucose control in subjects with type 2 diabetes: a multicenter, double blind, randomized placebo-controlled trial of a novel probiotic formulation. BMJ Open Diabetes Research & Care, 8(1):e001319.
- Cani PD, Depommier C, Derrien M, Everard A, de Vos WM. (2022). Akkermansia muciniphila: paradigm for next-generation beneficial microorganisms. Nature Reviews Gastroenterology & Hepatology, 19:625–637.
- Original Welzo Akkermansia review: Best Akkermansia Supplements of 2026, According to Nutritionists
- Welzo Akkermansia muciniphila probiotics collection: https://welzo.com/collections/akkermansia-muciniphila-probiotics
- Welzo Pendulum collection: https://welzo.com/collections/pendulum
- Welzo Ultra Purity range: https://welzo.com/collections/welzo-ultra-purity-supplements
This article is for general information and is not a substitute for personalised medical advice. Always consult your GP or a qualified healthcare professional before starting any new supplement, particularly if you are pregnant, breastfeeding, immunocompromised, taking prescription medication (especially insulin or sulfonylureas), or managing a chronic health condition. Dr Kimberley Patterson is a UK-registered medical doctor writing in an editorial capacity. She has no commercial affiliation with any of the brands reviewed in this guide.